<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05610631</url>
  </required_header>
  <id_info>
    <org_study_id>Swiss PH Registry</org_study_id>
    <nct_id>NCT05610631</nct_id>
  </id_info>
  <brief_title>Pulmonary Hypertension Registry Switzerland</brief_title>
  <official_title>Swiss PH Registry - Cohort of Swiss PH Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Actelion</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Registry Data from PH-patients in Switzerland, who have given consent to records for research&#xD;
      purposes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">December 2027</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>6-minute walking distance</measure>
    <time_frame>within the study duration e.g. up to 10 years</time_frame>
    <description>6-minute walking distance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association functional class</measure>
    <time_frame>within the study duration e.g. up to 10 years</time_frame>
    <description>New York Heart Association functional class</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NTproBNP</measure>
    <time_frame>within the study duration e.g. up to 10 years</time_frame>
    <description>NTproBNP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>within the study duration e.g. up to 10 years</time_frame>
    <description>time to death analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication</measure>
    <time_frame>within the study duration e.g. up to 10 years</time_frame>
    <description>escalation of clinical therapy</description>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Pulmonary arterial hypertension</arm_group_label>
    <description>Pulmonary arterial hypertension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PH due to left heart diseases</arm_group_label>
    <description>PH due to left heart diseases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PH due to lung disease and/or hypoxia</arm_group_label>
    <description>PH due to lung disease and/or hypoxia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic thromboembolic PH</arm_group_label>
    <description>Chronic thromboembolic PH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Miscellaneous PH</arm_group_label>
    <description>Miscellaneous PH</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pulmonary Hypertension (PH)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with PH&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvia Ulrich, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UniversityHospital Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silvia Ulrich, Prof. Dr.</last_name>
    <phone>+41442552220</phone>
    <email>silvia.ulrich@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Respiratory Clinic, University Hospital of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Ulrich, Prof. Dr.</last_name>
      <phone>++41442554362</phone>
      <email>silvia.ulrich@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Konrad Bloch, Prof. Dr.</last_name>
      <phone>++41442551111</phone>
      <email>konrad.bloch@usz.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Silvia Ulrich, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 1, 2022</study_first_submitted>
  <study_first_submitted_qc>November 8, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2022</study_first_posted>
  <last_update_submitted>November 8, 2022</last_update_submitted>
  <last_update_submitted_qc>November 8, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

